Skip to main content
GWGovwatch
CongressBillsCommitteesPresidentMoneyPulseMisconductElectionsMap
Donate

Weekly accountability digest

One email a week with new votes, moving bills, and misconduct updates. No spam.

GW

Govwatch. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Predictions

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live

Site

  • About
  • Contact
  • Corrections
  • Privacy Policy
  • Terms of Service

Data Sources

Congress.gov API v3
Bills, members, votes
GovInfo API
Floor speeches, reports, bill text
Federal Election Commission (FEC)
Campaign finance
VoteView (UCLA)
Ideology scores (DW-NOMINATE)
GovTrack.us
Misconduct data (CC0)
U.S. Census Bureau
District demographics

Data Last Updated

Bills & Votes: 2 hours ago
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Govwatch

HR10133Referred to Committee

Fair Prescription Pricing Act of 2026

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-08-20
Introduced
0
Cosponsors
HR
ⓘ
Type

Sponsor

Hillary J. Scholten
Hillary J. Scholten
Democrat · MI · Representative
Votes with party: 93.6% (613 recorded votes)

Full profile: /officials/S001221

Source: Congress.gov · FEC

Cosponsors (0)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

No cosponsors on record. Bills can pass without cosponsors — this often means the sponsor introduced the bill alone, either because it's a messaging bill, a chairman's mark, or simply early in the legislative cycle.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

2026-08-20

Source: Congress.gov

Committee Activity

Currently in

  • House Committee on Education and WorkforceReferred To · 2026-08-20
  • House Committee on Energy and CommerceReferred To · 2026-08-20
  • House Committee on Ways and MeansReferred To · 2026-08-20

Plain-English Summary

Plain-English summary pending. Introduced on 2026-08-20. Check back soon — summaries are generated as bills progress through Congress.

Subjects

Health

Full Bill Text

Verbatim text published on Congress.gov via GovInfo. Use Cmd+F / Ctrl+F to search within this excerpt.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 10133 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 10133 To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to ensure cost sharing for a drug does not exceed the nationwide average of consumer purchase prices for such drug. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES August 20, 2026 Ms. Scholten introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned _______________________________________________________________________ A BILL To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to ensure cost sharing for a drug does not exceed the nationwide average of consumer purchase prices for such drug. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Fair Prescription Pricing Act of 2026''. SEC. 2. ENSURING COST SHARING FOR A DRUG DOES NOT EXCEED THE NATIONWIDE AVERAGE OF CONSUMER PURCHASE PRICES FOR SUCH DRUG. (a) PHSA.--Part D of title XXVII of the Public Health Service Act (42 U.S.C. 300gg-111 et seq.) is amended by adding at the end the following new section: ``SEC. 2799A-12. LIMITATION ON COST SHARING FOR DRUGS. ``(a) In General.--For plan years beginning on or after the date of the enactment of this section, a group health plan, and a health insurance issuer offering group or individual health insurance coverage, may not impose cost sharing (including deductibles, coinsurance, and copayments) with respect to a covered outpatient drug for which benefits are available under such plan or coverage dispensed by an in-network pharmacy in an amount that exceeds the nationwide average of consumer purchase prices for such drug for the 1-year period ending on the first day of such plan year (as determined using information from the survey described in section 1927(f)(1)(A)(i) of the Social Security Act). ``(b) Clarification on Application to Pharmacy Benefit Managers.--A group health plan, and a health insurance issuer offering group or individual health insurance coverage, shall ensure that any pharmacy benefit manager providing services under the plan or coverage complies with subsection (a) in the same manner as such subsection applies with respect to such plan or issuer. ``(c) Definitions.--In this section: ``(1) Covered outpatient drug.--The term `covered outpatient drug' has the meaning given such term in section 1927(k) of the Social Security Act. ``(2) In-network pharmacy.--The term `in-network pharmacy' means, with respect to a group health plan or group or individual health insurance coverage and a drug, a pharmacy with a contractual relationship in effect for dispensing such drug under such plan or coverage.''. (b) ERISA.-- (1) In general.--Subpart B of part 7 of subtitle B of title I of the Employee Retirement Income Security Act of 1974 (29 U.S.C. 1185 et seq.) is amended by adding at the end the following new section: ``SEC. 727. LIMITATION ON COST SHARING FOR DRUGS. ``(a) In General.--For plan years beginning on or after the date of the enactment of this section, a group health plan, and a health insurance issuer offering group coverage, may not impose cost sharing (including deductibles, coinsurance, and copayments) with respect to a covered…
Show the remaining 472 wordsHide the remaining 472 words
outpatient drug for which benefits are available under such plan or coverage dispensed by an in-network pharmacy in an amount that exceeds the nationwide average of consumer purchase prices for such drug for the 1-year period ending on the first day of such plan year (as determined using information from the survey described in section 1927(f)(1)(A)(i) of the Social Security Act). ``(b) Clarification on Application to Pharmacy Benefit Managers.--A group health plan, and a health insurance issuer offering group health insurance coverage, shall ensure that any pharmacy benefit manager providing services under the plan or coverage complies with subsection (a) in the same manner as such subsection applies with respect to such plan or issuer. ``(c) Definitions.--In this section: ``(1) Covered outpatient drug.--The term `covered outpatient drug' has the meaning given such term in section 1927(k) of the Social Security Act. ``(2) In-network pharmacy.--The term `in-network pharmacy' means, with respect to a group health plan or group health insurance coverage and a drug, a pharmacy with a contractual relationship in effect for dispensing such drug under such plan or coverage.''. (2) Clerical amendment.--The table of contents in section 1 of such Act is amended by inserting after the item relating to section 715 the following new item: ``Sec. 727. Limitation on cost sharing for drugs.''. (c) IRC.-- (1) In general.--Subchapter B of chapter 100 of the Internal Revenue Code of 1986 is amended by adding at the end the following new section: ``SEC. 9827. LIMITATION ON COST SHARING FOR DRUGS. ``(a) In General.--For plan years beginning on or after the date of the enactment of this section, a group health plan may not impose cost sharing (including deductibles, coinsurance, and copayments) with respect to a covered outpatient drug for which benefits are available under such plan dispensed by an in-network pharmacy in an amount that exceeds the nationwide average of consumer purchase prices for such drug for the 1-year period ending on the first day of such plan year (as determined using information from the survey described in section 1927(f)(1)(A)(i) of the Social Security Act). ``(b) Clarification on Application to Pharmacy Benefit Managers.--A group health plan shall ensure that any pharmacy benefit manager providing services under the plan complies with subsection (a) in the same manner as such subsection applies with respect to such plan. ``(c) Definitions.--In this section: ``(1) Covered outpatient drug.--The term `covered outpatient drug' has the meaning given such term in section 1927(k) of the Social Security Act. ``(2) In-network pharmacy.--The term `in-network pharmacy' means, with respect to a group health plan and a drug, a pharmacy with a contractual relationship in effect for dispensing such drug under such plan.''. (2) Clerical amendment.--The table of sections for such subchapter is amended by adding at the end the following new item: ``Sec. 9827. Limitation on cost sharing for drugs.''. <all>
Open clean-text viewRead on Congress.gov →

Related legislation

Bills by the same sponsor or covering overlapping subjects.

  • HR10134Local Health Care Protection Act of 2026
    Referred to Committee · 2026-08-20
  • HR10005Data Center Resource Disclosure Act
    Referred to Committee · 2026-07-30
  • HR10004Defending Our Energy and Water Act
    Referred to Committee · 2026-07-30
  • HR8999To designate the facility of the United States Postal Service located at 324 Washington Avenue, Suite 1 in Grand Haven, Michigan, as the "Ell Thomas Simantz Post Office Building".
    Reported by Committee · 2026-07-22